GII Innovation announced on the 20th that its board of directors has resolved to issue 11,644,800 shares through a ...

Most studies comparing coronary artery bypass graft patency are observational and opportunistic ... Second, the study was a large multicenter one, with graft data from >107 US sites. Most graft ...

The following is a summary of “Impact of frailty on outcomes following coronary artery bypass grafting: a systematic review ...

Hamad Medical Corporation's (HMC) Heart Hospital has expanded its use of surgical robots in coronary artery bypass grafting (Robotic CABG) surgeries. Robotic-assisted coronary artery bypass ...

ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: Summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ...

Aims: Coronary artery bypass grafts (CABGs) are increasingly performed in elderly patients. Risk factors and outcomes are poorly described for those undergoing noncardiac surgery within 1 year ...

This is known as coronary artery bypass grafting, also referred to as CABG (pronounced “cabbage”) or bypass surgery. In addition to relieving angina symptoms, another goal is to prevent a ...

The two-layer construction of FUSION grafts delivers benefits during and after peripheral bypass surgery: Axial compliance for better handling compared with standard ePTFE grafts High suture ...

As 2024 came to a close, Ascension Saint Thomas leadership reflected on strides in healthcare innovation, community care and ...

XyloCor Therapeutics Inc., a Wayne gene therapy company, received $67.5 million from investors to support Phase 2 trials of a treatment designed to grow new blood vessels in the heart, XyloCor ...